Tilray Brands

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Tilray Brands and other ETFs, options, and stocks.

About TLRY

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. 

CEO
Irwin David Simon
CEOIrwin David Simon
Employees
2,842
Employees2,842
Headquarters
Leamington, Ontario
HeadquartersLeamington, Ontario
Founded
2018
Founded2018
Employees
2,842
Employees2,842

TLRY Key Statistics

Market cap
1.18B
Market cap1.18B
Price-Earnings ratio
-0.45
Price-Earnings ratio-0.45
Dividend yield
Dividend yield
Average volume
33.00M
Average volume33.00M
High today
$10.89
High today$10.89
Low today
$9.97
Low today$9.97
Open price
$10.69
Open price$10.69
Volume
4.53M
Volume4.53M
52 Week high
$23.20
52 Week high$23.20
52 Week low
$3.51
52 Week low$3.51

Stock Snapshot

With a market cap of 1.18B, Tilray Brands(TLRY) trades at $10.09. The stock has a price-to-earnings ratio of -0.45.

On 2025-12-25, Tilray Brands(TLRY) stock moved within a range of $9.97 to $10.89. With shares now at $10.09, the stock is trading +1.2% above its intraday low and -7.3% below the session's peak.

Trading volume for Tilray Brands(TLRY) stock has reached 4.53M, versus its average volume of 33M.

The stock's 52-week range extends from a low of $3.51 to a high of $23.20.

The stock's 52-week range extends from a low of $3.51 to a high of $23.20.

TLRY News

Nasdaq 24h
This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next

Key Points Tilray's shares have soared since mid-2025, driven by expectations of cannabis reclassification in the U.S. These expectations have now become a re...

This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next
Nasdaq 2d
President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?

Key Points Trump's executive order to reclassify marijuana from Schedule I to Schedule III recognized the valid medical uses of the drug. The move could impac...

President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?
The Motley Fool 6d
Why Tilray Stock Dropped This Week, Even After President Trump's Executive Order

Why did Tilray's 30% gain evaporate this week? It was an exciting week in the cannabis sector. Rumors that President Trump was planning to reclassify marijuana...

Why Tilray Stock Dropped This Week, Even After President Trump's Executive Order

Analyst ratings

64%

of 11 ratings
Buy
36.4%
Hold
63.6%
Sell
0%

More TLRY News

Nasdaq 6d
Stock Market Today, Dec. 18: Tilray Brands Jumps After Trump Order Spurs Cannabis Rescheduling

Tilray Brands (NASDAQ:TLRY), a global medical cannabis producer, closed Thursday at $12.34, down 4.2%. Tilray Brands IPO'd in 2018 and has fallen 94% since goin...

Stock Market Today, Dec. 18: Tilray Brands Jumps After Trump Order Spurs Cannabis Rescheduling
TipRanks 7d
Tilray accelerates U.S. medical cannabis expansion after federal rescheduling

Tilray (TLRY) Medical, a division of Tilray Brands, confirmed its planned strategic framework to advance its U.S. medical cannabis operations following federal...

Sherwood News 7d
Trump signs executive order expediting reclassification of marijuana as a less dangerous drug

Rescheduling would lift regulatory pressures that have been weighing on US cannabis operators' margins. Shares of weed companies, many of which don’t sell canna...

Trump signs executive order expediting reclassification of marijuana as a less dangerous drug

People also own

Based on the portfolios of people who own TLRY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.